Digital therapeutics in neurology
- PMID: 34018047
- PMCID: PMC8136262
- DOI: 10.1007/s00415-021-10608-4
Digital therapeutics in neurology
Abstract
Digital therapeutics (DTx) is a section of digital health defined by the DTx Alliance as "delivering evidence-based therapeutic interventions to patients that are driven by software to prevent, manage, or treat a medical disorder or disease. They are used independently or in concert with medications, devices, or other therapies to optimize patient care and health outcomes". Chronic disabling diseases could greatly benefit from DTx. In this narrative review, we provide an overview of DTx in the care of patients with neurological dysfunctions.
Keywords: Digital therapeutics; Exergames; Neurological disorders; Rehabilitation; Validation studies.
© 2021. The Author(s).
Conflict of interest statement
The authors declare that there is no conflict of interest regarding the publication of this article.
Similar articles
-
Digital Therapeutics in Urology: An Innovative Approach to Patient Care and Management.Eur Urol Open Sci. 2023 Aug 4;55:23-27. doi: 10.1016/j.euros.2023.07.003. eCollection 2023 Sep. Eur Urol Open Sci. 2023. PMID: 37593208 Free PMC article.
-
Digital Therapeutics as a New Therapeutic Modality: A Review from the Perspective of Clinical Pharmacology.Clin Pharmacol Ther. 2023 Sep;114(3):578-590. doi: 10.1002/cpt.2989. Epub 2023 Jul 10. Clin Pharmacol Ther. 2023. PMID: 37392464 Review.
-
Appropriate controls for digital therapeutic clinical trials: A narrative review of control conditions in clinical trials of digital therapeutics (DTx) deploying psychosocial, cognitive, or behavioral content.Front Digit Health. 2022 Aug 18;4:823977. doi: 10.3389/fdgth.2022.823977. eCollection 2022. Front Digit Health. 2022. PMID: 36060538 Free PMC article. Review.
-
Digital therapeutics as a new weapon against diseases: focus on the current European legislation and possible therapeutic strategies.Expert Rev Med Devices. 2025 Jan-Feb;22(2):141-147. doi: 10.1080/17434440.2025.2457468. Epub 2025 Jan 25. Expert Rev Med Devices. 2025. PMID: 39846979 Review.
-
The Revolution of Digital Therapeutics (DTx) in the Pharmaceutical Industry and Their Quality Impacts.Cureus. 2024 Aug 13;16(8):e66792. doi: 10.7759/cureus.66792. eCollection 2024 Aug. Cureus. 2024. PMID: 39268306 Free PMC article. Review.
Cited by
-
Exploring the potential of digital therapeutics: An assessment of progress and promise.Digit Health. 2024 Sep 12;10:20552076241277441. doi: 10.1177/20552076241277441. eCollection 2024 Jan-Dec. Digit Health. 2024. PMID: 39291152 Free PMC article. Review.
-
Efficacy of the therapeutic use of video games on the depressive state of stroke patients: Protocol for systematic review and meta-analysis.PLoS One. 2022 Dec 28;17(12):e0275740. doi: 10.1371/journal.pone.0275740. eCollection 2022. PLoS One. 2022. PMID: 36576909 Free PMC article.
-
A protocol for the evaluation of a wearable device for monitoring of symptoms, and cueing for the management of drooling, in people with Parkinson's disease.PLoS One. 2023 Feb 24;18(2):e0280727. doi: 10.1371/journal.pone.0280727. eCollection 2023. PLoS One. 2023. PMID: 36827274 Free PMC article.
-
Digital therapeutics from bench to bedside.NPJ Digit Med. 2023 Mar 10;6(1):38. doi: 10.1038/s41746-023-00777-z. NPJ Digit Med. 2023. PMID: 36899073 Free PMC article.
-
Multiple Sclerosis: Diagnosis, Management, and Future Opportunities.J Clin Med. 2023 Jul 8;12(14):4558. doi: 10.3390/jcm12144558. J Clin Med. 2023. PMID: 37510673 Free PMC article.
References
-
- WHO guideline Recommendations on Digital Interventions for Health System Strengthening. Geneva: World Health Organization; 2019. Available from: https://www.ncbi.nlm.nih.gov/books/NBK541905/ - PubMed
-
- Lavorgna L, Brigo F, Moccia M, et al. e-Health and multiple sclerosis: an update. Mult Scler. 2018;24(13):1657–1664. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources